China Property SectorNBS Nov data in line, expect new policy in BJ/SH to boost secondary market in Dec
2024 earnings way below expectations; outlook remains challenging
China Policy:Credit growth is expected to rebound in 2023
China Pharmaceutical & Healthcare - Expecting global funding recovery in the coming quarters
China Property Sector: NBS Nov data in line, expect new policy in BJ/SH to boost secondary market in Dec
1Q23E profit beat expectations; Multiple catalysts ahead
1H24 preview: margin weakness priced in; expect gradual ASP/margin recovery in 2H
China Sportswear Sector – We expect prudent guidance but decent margins
Expect sustainable DPS growth onwards
Core net profit in 2022 +53% YoY in line with expectation; Margin recovery in 4Q